NLS Pharma article

Once limited to decongestants, nasal drug delivery is emerging as one of medicine’s most promising frontiers, offering faster uptake, stronger immunity, and the potential to block transmission before disease takes hold.

Ipsen is relocating its Nordic headquarters from Kista to Hagastaden, one of Stockholm’s most dynamic life science hubs.

The company is part of a new EU‑funded consortium developing an AI‑ and robotics‑driven manufacturing platform to secure access to critical medicines during shortages and supply chain disruptions.

Nasal drug delivery is a dynamic area in pharmaceutical innovation. What was once a route for decongestants and allergy sprays is now being explored for everything from emergency treatments to vaccines – and even shows potential for future central nervous system therapies.

Alfa Laval has implemented a transformation of its organization to establish the Food & Pharma Division.

A large-scale Nordic collaboration has developed the research on personalized pharmaceuticals and led to researcher training and mobility, new patient-oriented products, new technologies and startups.